Company Filing History:
Years Active: 2006
Title: Matthias G Ssel: Innovator in Pharmaceutical Chemistry
Introduction
Matthias G Ssel is a notable inventor based in Hofheim, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have potential applications in treating obesity and type II diabetes.
Latest Patents
One of his key patents is titled "C2-disubstituted indan-1-ol compounds, their derivatives, processes for their preparation, and their use as pharmaceuticals." This invention focuses on C2-disubstituted indan-1-ol systems, which include physiologically acceptable salts and functional derivatives. These compounds are particularly useful for reducing weight and for the prophylaxis or treatment of obesity and type II diabetes in mammals. The patent also outlines methods for reducing weight and processes for the preparation of these compounds.
Career Highlights
Matthias G Ssel is associated with Aventis Pharma Deutschland GmbH, where he has been instrumental in advancing pharmaceutical research. His work has led to innovative solutions in the treatment of metabolic disorders, showcasing his expertise in the field.
Collaborations
Throughout his career, Matthias has collaborated with esteemed colleagues such as Gerhard Jaehne and Volker Krone. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical solutions.
Conclusion
Matthias G Ssel's contributions to pharmaceutical chemistry, particularly through his innovative patent, highlight his role as a key inventor in the industry. His work continues to pave the way for advancements in the treatment of obesity and diabetes.